Monday 20 June 2022
Alphagenix International FZCO, a provider of medically supervised hormone optimization and testosterone replacement therapy, has opened an office at Dubai Digital Park in Dubai Silicon Oasis and is part of the company’s plan to expand globally.
Founded in 2021, UK-headquartered Alphagenix focuses on improving the quality of life for men through education, investigation, diagnosis, and the treatment of low testosterone levels.
Alphagenix is currently looking for opportunities in the healthcare space, particularly acquisitions and investments in businesses within its main verticals.
Dubai Digital Park is a new smart city at Dubai Silicon Oasis, an integrated free zone with a hi-tech ecosystem. Spanning an area of 150,000 square meters, the mixed-use development hosts contemporary office buildings, modern apartments, and retail units.
Dubai plans to attract USD 2.5 billion in pharmaceutical investments by 2022, with a focus on attracting manufacturing super generics, nutraceuticals, 3D implants, and blood plasma.